omniture
广州市基准医疗有限责任公司 AnchorDx Medical Co. Ltd

Latest News

AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests

GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing ...

2023-11-13 21:00 2056

AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests

GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing ...

2023-11-13 21:00 2973

AnchorDx Enrolls the First Patient For Its UriFind® Bladder Cancer Assay Clinical Trial in the U.S.

GUANGZHOU, China, Nov. 23, 2022 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer early...

2022-11-23 22:00 4632

AnchorDx's Non-invasive Lung Cancer Early Diagnosis Product, PulmoSeek, Completes EU CE Marking Requirements

The company obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by...

2022-06-15 21:00 3257

AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer

GUANGZHOU, China, March 7, 2022 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer scree...

2022-03-07 09:00 3186

AnchorDx Achieves Academic Breakthrough with Deep Methylation Representation Learning Research Paper Accepted by 36th AAAI Conference

GUANGZHOU, China, Dec. 9, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screen...

2021-12-09 22:00 3381

Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy

GUANGZHOU, China, Oct. 11, 2021 /PRNewswire/ -- The Twist Alliance Pan-Cancer Methylation Panel (Pa...

2021-10-11 21:00 4442

AnchorDx Develops New Liquid Biopsy Diagnostic Model for Early Detection of Breast Cancer

GUANGZHOU, China, Sept. 13, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer scre...

2021-09-13 21:00 3579